Neurodegenerative Disease and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neurodegenerative Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurodegenerative Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurodegenerative Disease Overall Market Size
2.1 Global Neurodegenerative Disease Market Size: 2023 VS 2030
2.2 Global Neurodegenerative Disease Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurodegenerative Disease Players in Global Market
3.2 Top Global Neurodegenerative Disease Companies Ranked by Revenue
3.3 Global Neurodegenerative Disease Revenue by Companies
3.4 Top 3 and Top 5 Neurodegenerative Disease Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neurodegenerative Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurodegenerative Disease Players in Global Market
3.6.1 List of Global Tier 1 Neurodegenerative Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurodegenerative Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurodegenerative Disease Market Size Markets, 2023 & 2030
4.1.2 NMDA
4.1.3 SSRIs
4.1.4 Dopamine Inhibitors
4.2 By Type - Global Neurodegenerative Disease Revenue & Forecasts
4.2.1 By Type - Global Neurodegenerative Disease Revenue, 2019-2024
4.2.2 By Type - Global Neurodegenerative Disease Revenue, 2025-2030
4.2.3 By Type - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurodegenerative Disease Market Size, 2023 & 2030
5.1.2 Parkinson?s Disease
5.1.3 Huntington Disease
5.1.4 Amyotrophic Lateral Sclerosis
5.1.5 Alzheimer?s Disease
5.2 By Application - Global Neurodegenerative Disease Revenue & Forecasts
5.2.1 By Application - Global Neurodegenerative Disease Revenue, 2019-2024
5.2.2 By Application - Global Neurodegenerative Disease Revenue, 2025-2030
5.2.3 By Application - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neurodegenerative Disease Market Size, 2023 & 2030
6.2 By Region - Global Neurodegenerative Disease Revenue & Forecasts
6.2.1 By Region - Global Neurodegenerative Disease Revenue, 2019-2024
6.2.2 By Region - Global Neurodegenerative Disease Revenue, 2025-2030
6.2.3 By Region - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neurodegenerative Disease Revenue, 2019-2030
6.3.2 US Neurodegenerative Disease Market Size, 2019-2030
6.3.3 Canada Neurodegenerative Disease Market Size, 2019-2030
6.3.4 Mexico Neurodegenerative Disease Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neurodegenerative Disease Revenue, 2019-2030
6.4.2 Germany Neurodegenerative Disease Market Size, 2019-2030
6.4.3 France Neurodegenerative Disease Market Size, 2019-2030
6.4.4 U.K. Neurodegenerative Disease Market Size, 2019-2030
6.4.5 Italy Neurodegenerative Disease Market Size, 2019-2030
6.4.6 Russia Neurodegenerative Disease Market Size, 2019-2030
6.4.7 Nordic Countries Neurodegenerative Disease Market Size, 2019-2030
6.4.8 Benelux Neurodegenerative Disease Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neurodegenerative Disease Revenue, 2019-2030
6.5.2 China Neurodegenerative Disease Market Size, 2019-2030
6.5.3 Japan Neurodegenerative Disease Market Size, 2019-2030
6.5.4 South Korea Neurodegenerative Disease Market Size, 2019-2030
6.5.5 Southeast Asia Neurodegenerative Disease Market Size, 2019-2030
6.5.6 India Neurodegenerative Disease Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neurodegenerative Disease Revenue, 2019-2030
6.6.2 Brazil Neurodegenerative Disease Market Size, 2019-2030
6.6.3 Argentina Neurodegenerative Disease Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurodegenerative Disease Revenue, 2019-2030
6.7.2 Turkey Neurodegenerative Disease Market Size, 2019-2030
6.7.3 Israel Neurodegenerative Disease Market Size, 2019-2030
6.7.4 Saudi Arabia Neurodegenerative Disease Market Size, 2019-2030
6.7.5 UAE Neurodegenerative Disease Market Size, 2019-2030
7 Neurodegenerative Disease Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Neurodegenerative Disease Major Product Offerings
7.1.4 Novartis Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Neurodegenerative Disease Major Product Offerings
7.2.4 Pfizer Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.2.5 Pfizer Key News & Latest Developments
7.3 Merck Serono
7.3.1 Merck Serono Company Summary
7.3.2 Merck Serono Business Overview
7.3.3 Merck Serono Neurodegenerative Disease Major Product Offerings
7.3.4 Merck Serono Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.3.5 Merck Serono Key News & Latest Developments
7.4 Biogen Idec
7.4.1 Biogen Idec Company Summary
7.4.2 Biogen Idec Business Overview
7.4.3 Biogen Idec Neurodegenerative Disease Major Product Offerings
7.4.4 Biogen Idec Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.4.5 Biogen Idec Key News & Latest Developments
7.5 TEVA
7.5.1 TEVA Company Summary
7.5.2 TEVA Business Overview
7.5.3 TEVA Neurodegenerative Disease Major Product Offerings
7.5.4 TEVA Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.5.5 TEVA Key News & Latest Developments
7.6 UCB
7.6.1 UCB Company Summary
7.6.2 UCB Business Overview
7.6.3 UCB Neurodegenerative Disease Major Product Offerings
7.6.4 UCB Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.6.5 UCB Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Neurodegenerative Disease Major Product Offerings
7.7.4 Boehringer Ingelheim Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Neurodegenerative Disease Major Product Offerings
7.8.4 Sanofi Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Neurodegenerative Disease Major Product Offerings
7.9.4 GlaxoSmithKline Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Livzon Pharmaceutical
7.10.1 Livzon Pharmaceutical Company Summary
7.10.2 Livzon Pharmaceutical Business Overview
7.10.3 Livzon Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.10.4 Livzon Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.10.5 Livzon Pharmaceutical Key News & Latest Developments
7.11 Haisco Pharmaceutical
7.11.1 Haisco Pharmaceutical Company Summary
7.11.2 Haisco Pharmaceutical Business Overview
7.11.3 Haisco Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.11.4 Haisco Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.11.5 Haisco Pharmaceutical Key News & Latest Developments
7.12 Jingxin Pharmaceutical
7.12.1 Jingxin Pharmaceutical Company Summary
7.12.2 Jingxin Pharmaceutical Business Overview
7.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.12.4 Jingxin Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.12.5 Jingxin Pharmaceutical Key News & Latest Developments
7.13 Dongcheng Biochemicals
7.13.1 Dongcheng Biochemicals Company Summary
7.13.2 Dongcheng Biochemicals Business Overview
7.13.3 Dongcheng Biochemicals Neurodegenerative Disease Major Product Offerings
7.13.4 Dongcheng Biochemicals Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.13.5 Dongcheng Biochemicals Key News & Latest Developments
7.14 Hisun Pharmaceutical
7.14.1 Hisun Pharmaceutical Company Summary
7.14.2 Hisun Pharmaceutical Business Overview
7.14.3 Hisun Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.14.4 Hisun Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.14.5 Hisun Pharmaceutical Key News & Latest Developments
7.15 Luye Pharma
7.15.1 Luye Pharma Company Summary
7.15.2 Luye Pharma Business Overview
7.15.3 Luye Pharma Neurodegenerative Disease Major Product Offerings
7.15.4 Luye Pharma Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.15.5 Luye Pharma Key News & Latest Developments
7.16 Ark Pharmaceutical
7.16.1 Ark Pharmaceutical Company Summary
7.16.2 Ark Pharmaceutical Business Overview
7.16.3 Ark Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.16.4 Ark Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.16.5 Ark Pharmaceutical Key News & Latest Developments
7.17 Kanghong Pharmaceutical
7.17.1 Kanghong Pharmaceutical Company Summary
7.17.2 Kanghong Pharmaceutical Business Overview
7.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.17.4 Kanghong Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.17.5 Kanghong Pharmaceutical Key News & Latest Developments
7.18 Huahai Pharmaceutical
7.18.1 Huahai Pharmaceutical Company Summary
7.18.2 Huahai Pharmaceutical Business Overview
7.18.3 Huahai Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.18.4 Huahai Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.18.5 Huahai Pharmaceutical Key News & Latest Developments
7.19 BORA PHARMACEUTICALS
7.19.1 BORA PHARMACEUTICALS Company Summary
7.19.2 BORA PHARMACEUTICALS Business Overview
7.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Major Product Offerings
7.19.4 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.19.5 BORA PHARMACEUTICALS Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neurodegenerative Disease Market Opportunities & Trends in Global Market
Table 2. Neurodegenerative Disease Market Drivers in Global Market
Table 3. Neurodegenerative Disease Market Restraints in Global Market
Table 4. Key Players of Neurodegenerative Disease in Global Market
Table 5. Top Neurodegenerative Disease Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neurodegenerative Disease Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neurodegenerative Disease Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neurodegenerative Disease Product Type
Table 9. List of Global Tier 1 Neurodegenerative Disease Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurodegenerative Disease Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neurodegenerative Disease Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neurodegenerative Disease Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neurodegenerative Disease Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neurodegenerative Disease Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neurodegenerative Disease Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neurodegenerative Disease Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neurodegenerative Disease Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neurodegenerative Disease Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neurodegenerative Disease Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neurodegenerative Disease Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neurodegenerative Disease Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neurodegenerative Disease Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neurodegenerative Disease Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neurodegenerative Disease Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neurodegenerative Disease Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neurodegenerative Disease Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neurodegenerative Disease Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neurodegenerative Disease Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neurodegenerative Disease Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Company Summary
Table 31. Novartis Neurodegenerative Disease Product Offerings
Table 32. Novartis Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Neurodegenerative Disease Product Offerings
Table 36. Pfizer Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 37. Pfizer Key News & Latest Developments
Table 38. Merck Serono Company Summary
Table 39. Merck Serono Neurodegenerative Disease Product Offerings
Table 40. Merck Serono Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 41. Merck Serono Key News & Latest Developments
Table 42. Biogen Idec Company Summary
Table 43. Biogen Idec Neurodegenerative Disease Product Offerings
Table 44. Biogen Idec Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 45. Biogen Idec Key News & Latest Developments
Table 46. TEVA Company Summary
Table 47. TEVA Neurodegenerative Disease Product Offerings
Table 48. TEVA Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 49. TEVA Key News & Latest Developments
Table 50. UCB Company Summary
Table 51. UCB Neurodegenerative Disease Product Offerings
Table 52. UCB Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 53. UCB Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Neurodegenerative Disease Product Offerings
Table 56. Boehringer Ingelheim Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Neurodegenerative Disease Product Offerings
Table 60. Sanofi Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 61. Sanofi Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Neurodegenerative Disease Product Offerings
Table 64. GlaxoSmithKline Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Livzon Pharmaceutical Company Summary
Table 67. Livzon Pharmaceutical Neurodegenerative Disease Product Offerings
Table 68. Livzon Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 69. Livzon Pharmaceutical Key News & Latest Developments
Table 70. Haisco Pharmaceutical Company Summary
Table 71. Haisco Pharmaceutical Neurodegenerative Disease Product Offerings
Table 72. Haisco Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 73. Haisco Pharmaceutical Key News & Latest Developments
Table 74. Jingxin Pharmaceutical Company Summary
Table 75. Jingxin Pharmaceutical Neurodegenerative Disease Product Offerings
Table 76. Jingxin Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 77. Jingxin Pharmaceutical Key News & Latest Developments
Table 78. Dongcheng Biochemicals Company Summary
Table 79. Dongcheng Biochemicals Neurodegenerative Disease Product Offerings
Table 80. Dongcheng Biochemicals Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 81. Dongcheng Biochemicals Key News & Latest Developments
Table 82. Hisun Pharmaceutical Company Summary
Table 83. Hisun Pharmaceutical Neurodegenerative Disease Product Offerings
Table 84. Hisun Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 85. Hisun Pharmaceutical Key News & Latest Developments
Table 86. Luye Pharma Company Summary
Table 87. Luye Pharma Neurodegenerative Disease Product Offerings
Table 88. Luye Pharma Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 89. Luye Pharma Key News & Latest Developments
Table 90. Ark Pharmaceutical Company Summary
Table 91. Ark Pharmaceutical Neurodegenerative Disease Product Offerings
Table 92. Ark Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 93. Ark Pharmaceutical Key News & Latest Developments
Table 94. Kanghong Pharmaceutical Company Summary
Table 95. Kanghong Pharmaceutical Neurodegenerative Disease Product Offerings
Table 96. Kanghong Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 97. Kanghong Pharmaceutical Key News & Latest Developments
Table 98. Huahai Pharmaceutical Company Summary
Table 99. Huahai Pharmaceutical Neurodegenerative Disease Product Offerings
Table 100. Huahai Pharmaceutical Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 101. Huahai Pharmaceutical Key News & Latest Developments
Table 102. BORA PHARMACEUTICALS Company Summary
Table 103. BORA PHARMACEUTICALS Neurodegenerative Disease Product Offerings
Table 104. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue (US$, Mn) & (2019-2024)
Table 105. BORA PHARMACEUTICALS Key News & Latest Developments
List of Figures
Figure 1. Neurodegenerative Disease Segment by Type in 2023
Figure 2. Neurodegenerative Disease Segment by Application in 2023
Figure 3. Global Neurodegenerative Disease Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neurodegenerative Disease Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neurodegenerative Disease Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurodegenerative Disease Revenue in 2023
Figure 8. By Type - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neurodegenerative Disease Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neurodegenerative Disease Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 16. US Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 20. Germany Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 21. France Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 28. China Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 32. India Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 34. Brazil Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neurodegenerative Disease Revenue Market Share, 2019-2030
Figure 37. Turkey Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neurodegenerative Disease Revenue, (US$, Mn), 2019-2030
Figure 41. Novartis Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Pfizer Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Merck Serono Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Biogen Idec Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. TEVA Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. UCB Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Boehringer Ingelheim Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Sanofi Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. GlaxoSmithKline Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Livzon Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Haisco Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Jingxin Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Dongcheng Biochemicals Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Hisun Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Luye Pharma Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Ark Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Kanghong Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Huahai Pharmaceutical Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
